Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 625 of 994 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/13/06
End: 07/06/07
Due: 07/06/08
Phase: N/A
Priority: Normal
Start: 04/30/97
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 10/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/02
End: 07/31/03
Due: 07/31/04
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/04/23
End: 10/02/25
Due: 10/02/26
Phase: N/A
Priority: Normal
Start: 01/07/14
End: 09/11/14
Due: 09/11/15
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 02/22/16
End: 06/30/20
Due: 06/30/21
GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound
Phase: N/A
Priority: Normal
Start: 04/18/13
End: 07/29/16
Due: 07/29/17
Phase: N/A
Priority: Normal
Start: 04/13/16
End: 05/02/17
Due: 05/02/18
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 02/06/18
End: 01/08/20
Due: 01/08/21
Phase: N/A
Priority: Normal
Start: 01/17/17
End: 10/06/22
Due: 10/06/23
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 08/31/02
End: 09/30/03
Due: 09/30/04
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 11/22/11
End: 08/10/18
Due: 08/10/19
Phase: N/A
Priority: Normal
Start: 11/28/11
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 02/01/03
End: 01/23/08
Due: 01/23/09
Phase: N/A
Priority: Normal
Start: 09/13/22
End: 05/31/23
Due: 05/31/24